There is a basic structure common to all immunoglobulin molecules. This comprises a pair of heavy polypeptide chains which characterize each immunoglobulin class (y for IgG, a for IgA, and ,u for IgM), and a pair of light chains (K or L) which is common to all immunoglobulin classes. Reductive cleavage of the immunoglobulin molecule by papain yields two Fab fragments each consisting of a light chain and part of a heavy chain, and an Fc fragment comprising the portions of the two heavy chains which carry the specific determinants characterizing each immunoglobulin class.
In many lymphoid-plasmocytic disorders such as multiple myeloma, abnormal plasma cells produce an excess of a specific immunoglobulin class with free light chains or an excess of free light chains alone. In 1964, a new syndrome was described in which abnormal plasma cells produced an anomalous polypeptide fragrnent, consisting of the Fc fragment of IgG (Franklin, Lowenstein, Bigelow, and Meltzer, 1964) . This condition was named 'heavy chain disease'. Similar disorders of immunoglobulin peptide synthesis and assembly have been described for IgA, the condition of 'alpha chain disease' (Rambaud, Bognel, Prost, Bernier, Le Quintrec, Lambling, Danon, Hurez, and Seligmann, 1968) and IgM, 'mu chain disease' (Ballard, Hamil- ton, Marcus, and Illes, 1970) . Subsequent case 'Present address: Department of Chemical Pathology, Westminster Hospital, London.
Received for publication 16 October 1972. 947 reports of alpha chain disease (Doe, Hobbs, Henry, and Dowling, 1970; Laroche, Seligmann, Merillon, Turpin, Marche, Cerf, Lemaigre, Forest, and Hurez, 1970; Roge, Druet, and Marche, 1970; Irunberry, Benallegue, Illoul, Timsit, Abbadi, Benabdallah, Boucekkine, Ould-Aoudia, and Colonna, 1970; Zlotnick and Levy, 1971) have described a strikingly uniform clinico-pathological picture.
The purpose of this paper is to describe five patients suffering from alpha chain disease presenting several new features. A simple new diagnostic method for detecting the alpha heavy chain fragment and the clinical course and response to cytotoxic therapy in three of these patients will be described.
Materials and Methods

BIOPSIES
Peroral jejunal biopsies were taken from beyond the ligament of Treitz using a Crosby capsule. Biopsy tissue was processed and stained for light and electron microscopy using standard techniques.
PROTEIN STUDIES
Electrophoresis was carried out on cellulose acetate and immunoelectrophoresis by the high-voltage method of Wieme (1965) . The immunoselection plate method of Radl (1970) Albumin and immunoglobulin levels were measured by a radial immunodiffusion method (Hobbs, 1970) The vast majority of cells in case 3 showed the cytoLight microscopy plasmic and nuclear structure of plasma cells The jejunal mucosa in all the biopsy specimens (Fig. 4) . Most were rounded with round to oval, (Fig. 7) , in jejunal fluid of cases 3 and 4 and in the urine of cases 3, 4, and 5. Free alpha chain was detected in the saliva of case 4 but none was found in the jejunal fluid of case 5 or the saliva of cases 3 and 5 (Table  V) .
Following thin-layer chromatography of sera in Sephadex G200, immunodiffusion was used to detect alpha chain arcs. These developed mainly opposite the 2% blue dextran marker (19S or showed a reaction of identity with alpha chain protein of known subclass alpha,. All, therefore, belonged to the alpha, subclass.
Following incubation of the jejunal biopsy from case 3 in a tissue culture containing tritiated leucine and tritiated lysine, immunoelectrophoresis and autoradiography were carried out on concentrated tissue culture material. The alpha chain arc, which was detected using a specific anti-alpha chain antiserum absorbed with an IgA-deficient saliva, was heavily labelled confirming that free alpha chain protein had been synthesised during the period of culture.
Using standard radial immunodiffusion, normal serum and polyclonal IgA standard behave with identical parallelism when the log of concentrations is plotted against the diameters of precipitin rings. Serum Cases 3, 4, and 5 were treated with long-term intermittent cytotoxic therapy. In case 3, Melphalan, 10 mg daily for one week every six weeks, was commenced in December 1969. Two months later, the weight had increased by 2 kg, diarrhoea had ceased, and abdominal pain was diminished. There was a progressive rise in serum albumin from 2.4 to 3.8 g/100 ml, IgG from 620 to 1100 mg/100 ml, and IgM from 24 to 41 mg/100 ml. Electrophoresis revealed a decrease in the abnormal alpha chain band. In May 1970, the patient ceased cytotoxic therapy and the diarrhoea and abdominal pain recurred. Investigation revealed an increase in faecal fat excretion (115 g/24 hours) and in the serum alpha2-beta protein band. Jejunal biopsy appearances were unchanged, except for an increase in the number of mast cells. Melphalan therapy was begun again, together with intermittent prednisone therapy (40 mg/day). His weight increased by 4 kg . A. 1': A Fig. 6 Cellulose acetate electrophoresis of sera from cases 1, 2, 3, and 4. Note reduction of slow y-globulin levels in the sera of all four patients. The o-chain regions are indicated by dotted areas and are readily obvious as a diffuse fi-y hump in patients 1, 2, and 3. In patient 3 freshly run jejunal juice reveals a dominant narrow band in the P2 position, proven to be due to free ai-chain. over the next three months and diarrhoea ceased. There was a progressive diminution in the abnormal alpha2-beta band (Fig. 8) . At this time jejunal biopsies showed more mature plasma cells. At present the patient is symptom-free and maintains his normal weight.
In case 4, who was initially unable to tolerate oral cytotoxic therapy, parenteral cyclophosphamide (100-200 mg daily) was given, together with a fiveday course of oral prednisone therapy (60 mg daily). A month later his weight began to increase, diarrhoea improved, and the abdominal pains ceased. Faecal fat excretion improved from 21-4 g/24 hours to 13.2 g/24 hours. After three months' therapy, the patient remains well.
In case 5 symptoms remitted following intermittent Melphalan, together with tetracycline therapy 500 mg twice daily. He remains well six months after diagnosis.
Discussion
These patients are similar to those with alpha chain disease previously described by Seligmann (Seligmann, Mihaesco, and Frangione, 1971) . The age range of 17 to 36, the clinical picture of abdominal pain, malabsorption, and clubbing, and the characteristic dense, predominantly plasma cell infiltrate of the small intestine, are associated with the 13.11.69.
22.1.71 .
AJ 955 presence of free alpha chain protein in serum, urine, and jejunal juice. The condition should, therefore, be suspected in any patient with malabsorption, a jejunal biopsy showing a diffuse plasma cell infiltration and an abnormal protein strip on electrophoresis. This paper adds a number of new findings to previous studies of alpha chain disease. These are: (1) an extension of the geographical incidence beyond the Mediterranean area; (2) spread of plasmacytosis beyond the intestinal tract, mesenteric nodes, and bone marrow; (3) the development of a new, simple diagnostic technique for the detection of free alpha chain protein; (4) response to intermittent cytotoxic therapy in three patients. The series adds Bangladesh, Greece, Libya, Pakistan, and Persia to the now diverse geographical and ethnic origins of patients suffering from alpha chain disease. Whereas early reports of this disease were confined to patients with 'Mediterranean lymphoma' from the Middle East and North Africa (Rambaud et al, 1968; Roge et al, 1970; Irrunberry et al, 1970) recently alpha chain disease has been described in Columbia, Argentina, Cambodia (Seligmann et al, 1971) , Holland (Stoop, Ballieux, Hijmans, and Zegers, 1971) , and probably in South Africa (Novis, Bank, Marks, Selzer, Kahn, and Sealy, 1971) . In view of the wide geographical distribution and the apparent rarity of this condition in western countries, it has been suggested that intestinal k.e.71 . Fig. 8 Cellulose acetate electrophoresis of three successive sera from patient 3: before treatment (13.11.69), after treatment but relapsing due to lack of continued treatment (22.1.71), andfinally after prolonged treatment with melphalan and prednisone (4.6.71) when little free oa-chain could be detected.
infection, possibly parasitic, may be the common factor in these patients, providing a stimulus for excess proliferation of intestinal IgA synthesizing plasma cells (Seligmann et al, 1971) .
A remarkable feature of all but one of the patients so far described with alpha chain disease is the initial confinement of the abnormal plasma cells to the wall of the small intestine. In the one exceptional case of alpha chain disease, only the lung appeared to be involved (Stoop et al, 1971) .
Alpha chain disease differs quite clearly from soft tissue plasmacytomata. Of 228 patients with soft tissue plasmacytomata studied, 36 had involvement of the alimentary tract and in only eight of these was the tumour confined to the small intestine (Wiltshaw, 1969) . Protein studies were carried out in a further series of soft tissue plasmacytomata. Of nine patients with gut plasmacytomata, eight had detectable paraproteins, five being IgG, two Bence Jones protein only, and one produced monoclonal 7S IgA. No secretory IgA was found in any of these tumours. IgA paraproteins were found in four soft tissue plasmacytomata not involving the gut. Both subclasses of IgA occurred and no free alpha chain was detected (Hobbs, 1972) . Alpha chain disease thus uniquely arises in the intestinal or bronchial subepithelial tissue and so far only involves the alpha, subclass of plasma cells.
The histological appearances of the jejunal mucosa showed a uniform abnormality in all five patients. Invasion of the submucosa was present in case 1 and possibly also in case 4 and evidence of spread beyond the intestine was obtained in cases 3 and 4. In case 4, abnormal plasma cells appeared in the circulation, but these cells disappeared within two weeks of commencing cytotoxic therapy. The findings at ultrastructural level in case 5 clearly resembled those described in two cases of alpha chain disease (Scotto, Stralin, and Caroli, 1970) . Case 3 differed, however, in that the plasma cells were more immature and in case 4 there were many cells of the intermediate lymphocytoid plasma cell type.
The immunoselection plate (Radl, 1970) incorporating anti-K and anti-L light chains to precipitate all immunoglobulin molecules containing light chains, offers the clearest method of demonstrating the presence of free alpha chains or portions thereof. Such fragments were regularly found in the serum of these patients and also in jejunal fluid in cases 3 and 4 where the alpha chain was not associated with secretory piece. This finding conflicts with an earlier report by Seligmann, Mihaesco, Hurez, Mihaesco, Preud'homme, and Rambaud (1969) who found secretory piece associated with alpha chain in jejunal fluid.
In addition, free alpha chain protein was found in concentrated urine in cases 3, 4, and 5, and jejunal biopsy culture fluid in case 3. The alpha chains in all patients belonged to the alpha, subclass identical to the first patient (T.L.) described with alpha chain disease (Rambaud et al, 1968) and all subsequent patients known (Seligmann et al, 1971 ). All five patients showed low serum levels of IgG and IgM. While the former could in part be due to increased catabolism consequent on protein-losing enteropathy, the levels of IgM were far lower than is usual from this cause alone (Waldmann, Gordon, Dutcher, and Wertlake, 1962) .
Fluorescent studies frequently revealed that the abnormal plasma cells contained no light chains and less than the expected quantities of heavy chains. This could result from rapid excretion of newly synthesised alpha chain, but in cases 3 and 4 the endoplasmic reticulum appeared to be bulging with protein. This could support the hypothesis of intracellular proteolysis of alpha chains proposed by Seligmann et al (1971) .
The level of free alpha chain in the sera and secretions of patients cannot be accurately measured by current methods. Our own study shows that it is valueless to measure IgA levels by radial immunodiffusion in these patients and in view of the variable degree of polymerization this method cannot be used to follow progress. On electrophoresis the zone is too diffuse and overlies other proteins so that area measurements are invalidated. Thus only a rough guide to treatment can be obtained by inspecting the cellulose acetate scans, although when alpha chain can no longer be detected by the immunoselection plate it has probably fallen below 30 mg/ 100 ml.
Intermittent cytotoxic therapy using Melphalan or cyclophosphamide with intermittent steroid therapy produced remissions in the three patients treated. Tetracyline was added to the regime in case 5 following recent reports of a remission achieved in a patient with alpha chain disease who was treated with long-term, broad-spectrum antibiotics alone (Roge et al, 1970) . The longest followup period in this series is three years. This patient (case 3) remains well with no detectable alpha chain protein in serum and with a greatly improved, though still abnormal, jejunal biopsy.
